ConductScience.org, home

Paper13680264

Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.

Kawai H and 2 others. Arch Gynecol Obstet, 2004. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy. Papers, record 13680264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/13680264

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
PubMed
Journal
Arch Gynecol Obstet
PubMed
Year
2004
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2015-11-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kawai HHaruko
2Furuhashi MMadoka
3Suganuma NNobuhiko

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Estrogen Replacement TherapyMajor topic
Follicle Stimulating HormoneMajor topic
Osteoporosis, PostmenopausalMajor topic
Adult
Aged
Biomarkers
Bone Density
Estradiol
Female
Humans
Luteinizing Hormone
Medical Records
Middle Aged
Predictive Value of Tests
Retrospective Studies

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42739753Is Follicle-Stimulating Hormone (FSH) Misnamed? Rethinking Its Role in Menopause as a Systemic Regulator of Bone, Brain, Metabolism, and Aging.J Clin Med2026https://conductscience.org/library/papers/42739753PubMed
39633710Research progress on FSH-FSHR signaling in the pathogenesis of non-reproductive diseases.Front Cell Dev Biol2024https://conductscience.org/library/papers/39633710PubMed
39394788Higher FSH Level Is Associated With Increased Risk of Incident Hip Fracture in Older Adults, Independent of Sex Hormones.J Clin Endocrinol Metab2025https://conductscience.org/library/papers/39394788PubMed
37914684Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets.Nat Commun2023https://conductscience.org/library/papers/37914684PubMed
37715028Pituitary crosstalk with bone, adipose tissue and brain.Nat Rev Endocrinol2023https://conductscience.org/library/papers/37715028PubMed
37455904The complications of male hypogonadism: is it just a matter of low testosterone?Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37455904PubMed
36692543Follicle-stimulating hormone is associated with low bone mass in postmenopausal women.Osteoporos Int2023https://conductscience.org/library/papers/36692543PubMed
35992104FSH and bone: Comparison between males with central versus primary hypogonadism.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/35992104PubMed
35966744Efficacy and Safety of Moxibustion for Menopausal Obesity: A Multicentre, Randomized, Controlled Trial Protocol.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35966744PubMed
34948434Management of Osteoporosis in Men: A Narrative Review.Int J Mol Sci2021https://conductscience.org/library/papers/34948434PubMed
30713101Sex hormones and stroke: Beyond estrogens.Horm Behav2019https://conductscience.org/library/papers/30713101PubMed
30275766The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?Int J Med Sci2018https://conductscience.org/library/papers/30275766PubMed
30085049FSH, Bone Mass, Body Fat, and Biological Aging.Endocrinology2018https://conductscience.org/library/papers/30085049PubMed
29897433Regulation of Skeletal Homeostasis.Endocr Rev2018https://conductscience.org/library/papers/29897433PubMed
29555849Actions of pituitary hormones beyond traditional targets.J Endocrinol2018https://conductscience.org/library/papers/29555849PubMed
28538730Blocking FSH induces thermogenic adipose tissue and reduces body fat.Nature2017https://conductscience.org/library/papers/28538730PubMed
27199891Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies.Front Endocrinol (Lausanne)2016https://conductscience.org/library/papers/27199891PubMed
22561017Blocking FSH action attenuates osteoclastogenesis.Biochem Biophys Res Commun2012https://conductscience.org/library/papers/22561017PubMed
22350658Further evidence that FSH causes bone loss independently of low estrogen.Endocrine2012https://conductscience.org/library/papers/22350658PubMed
20428406Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis.Int J Gen Med2008https://conductscience.org/library/papers/20428406PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/13680264

GET https://conductscience.org/api/papers/v1/13680264/authors